P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients

P292 Cell-free DNA (cfDNA) profiling using Guardant360 in Japanese metastatic breast cancer patients

Bibliographic Details
Main Authors:	M. Kawashima, Y. Fujimoto, W. Tsuji, F. Yotsumoto, Y. Komi, H. Suwa, T. Taji, A. Izumi, M. Torii, Y. Matsutani, E. Suzuki, M. Tokiwa, N. Kawaguchi-Sakita, Y. Mori, A. Yamaguchi, K. Kawaguchi, M. Takada, M. Toi
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623004101

Similar Items

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

What fraction of cellular DNA turnover becomes cfDNA?
by: Ron Sender, et al.
Published: (2024-02-01)

Diagnostic Value of cfDNA in Pancreatic Cancer
by: XU Yijun, et al.
Published: (2022-12-01)

The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma
by: A-M Joëlle Marivel, et al.
Published: (2023-01-01)

Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
by: Zhong Y, et al.
Published: (2020-05-01)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
by: Corinna Keup, et al.
Published: (2022-03-01)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
by: Elodie Bohers, et al.
Published: (2021-06-01)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
by: Laura Gerard, et al.
Published: (2023-01-01)

Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.
by: Noelia Lozano, et al.
Published: (2023-01-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Plasma cfDNA in Carcinoma of unknown primary: A case series
by: Rajat Thawani, et al.
Published: (2024-03-01)

cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
by: Xiao-Hong Li, et al.
Published: (2022-12-01)

Dynamics of Specific cfDNA Fragments in the Plasma of Full Marathon Participants
by: Takehito Sugasawa, et al.
Published: (2021-04-01)

cfDNA Changes in Maximal Exercises as a Sport Adaptation Predictor
by: Kinga Humińska-Lisowska, et al.
Published: (2021-08-01)

Use of Internal Standards to Develop Improved Methylation Detection in cfDNA
by: Erin L> Crawford
Published: (2023-05-01)

Brave new world of cfDNA-omics for early cancer detection
by: Alessandro Russo, et al.
Published: (2023-09-01)

Hypertensive disorders of pregnancy share common cfDNA methylation profiles
by: Marialuigia Spinelli, et al.
Published: (2022-11-01)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
by: Leilei Liang, et al.
Published: (2022-09-01)

Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis
by: Gaia Viglianisi, et al.
Published: (2023-06-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
by: Ariane Hallermayr, et al.
Published: (2023-10-01)

Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis
by: Nicholas Kueng, et al.
Published: (2023-07-01)

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
by: Lucija Škara, et al.
Published: (2023-01-01)

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
by: Alicia-Marie Conway, et al.
Published: (2024-04-01)

Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy
by: Viola Bianca Serio, et al.
Published: (2022-06-01)

Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer
by: Jun Wang, et al.
Published: (2023-09-01)

Surveillance of cfDNA Hot Spot Mutations in NSCLC Patients during Disease Progression
by: Agne Sestokaite, et al.
Published: (2023-04-01)

Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem
by: Eleni Avramidou, et al.
Published: (2023-02-01)

cfDNA and DNases: New Biomarkers of Sepsis in Preterm Neonates—A Pilot Study
by: Moritz Lenz, et al.
Published: (2022-01-01)

Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer
by: Christian Linke, et al.
Published: (2023-03-01)

Novel nanogel offers potential treatment for rheumatoid arthritis by trapping and degrading cfDNA
by: Ru Li
Published: (2023-09-01)

Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer
by: Yael Bar, et al.
Published: (2024-04-01)

Effect of acute moderate-intensity cycling on cfDNA levels considering menstrual cycle phases
by: Akemi Sawai, et al.
Published: (2024-01-01)

P634: Development of a hemolysis index for Vanadis® cfDNA NIPT sample acceptance
by: Zhiwen Luo, et al.
Published: (2023-01-01)

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems
by: Lijing Zhang, et al.
Published: (2023-10-01)

CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy
by: Sonia Mayo, et al.
Published: (2022-04-01)

Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and cfDNA in Adipocytes
by: Alexandra Höpfinger, et al.
Published: (2023-10-01)

Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray
by: Erica Soster, et al.
Published: (2023-06-01)

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
by: Evangelos Mantios, et al.
Published: (2023-10-01)

Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis
by: Seong Eun Bak, et al.
Published: (2023-01-01)